Madrigal Pharmaceuticals, Inc. (MDGL)
538.76
-1.27
(-0.24%)
USD |
NASDAQ |
Sep 01, 16:00
538.76
0.00 (0.00%)
After-Hours: 17:23
Madrigal Pharmaceuticals Total Long Term Debt (Quarterly) : 346.72M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 346.72M |
| March 31, 2026 | 345.61M |
| December 31, 2025 | 346.61M |
| September 30, 2025 | 345.32M |
| June 30, 2025 | 122.90M |
| March 31, 2025 | 118.76M |
| December 31, 2024 | 118.59M |
| September 30, 2024 | 118.26M |
| June 30, 2024 | 117.51M |
| March 31, 2024 | 117.18M |
| December 31, 2023 | 116.67M |
| September 30, 2023 | 116.05M |
| June 30, 2023 | 99.25M |
| March 31, 2023 | 83.96M |
| December 31, 2022 | 49.29M |
| September 30, 2022 | 49.05M |
| June 30, 2022 | 48.85M |
| March 31, 2022 | 0.283M |
| December 31, 2021 | 0.387M |
| September 30, 2021 | 0.491M |
| June 30, 2021 | 0.594M |
| March 31, 2021 | 0.387M |
| December 31, 2020 | 0.468M |
| September 30, 2020 | 0.548M |
| June 30, 2020 | 0.197M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.279M |
| December 31, 2019 | 0.361M |
| September 30, 2019 | 0.441M |
| June 30, 2019 | 0.52M |
| March 31, 2019 | 0.598M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.032M |
| March 31, 2016 | 2.332M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 6.967M |
| June 30, 2015 | 9.282M |
| March 31, 2015 | 11.60M |
| December 31, 2014 | 13.91M |
| September 30, 2014 | 16.22M |
| June 30, 2014 | 18.52M |
| March 31, 2014 | 20.90M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Exelixis, Inc. | 165.93M |
| Karyopharm Therapeutics, Inc. | 255.12M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |